- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
5 result(s) found for: Gluten challenge.
Displaying page 1 of 1.
EudraCT Number: 2010-023127-23 | Sponsor Protocol Number: ALV003-1021 | Start Date*: 2010-10-25 | |||||||||||
Sponsor Name:Alvine Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 2a, Double-Blind, Placebo Controlled Trial of the Efficacy, Safety and Tolerability of 6-Weeks Treatment With Varying Methods of ALV003 Administration in Patients With Well-Controlled Celia... | |||||||||||||
Medical condition: Celiac Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-012221-10 | Sponsor Protocol Number: ALV003-0921 | Start Date*: 2009-07-21 | |||||||||||
Sponsor Name:Alvine Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 2a, Double Blind, Placebo Controlled Study of the Efficacy, Safety and Tolerability of 6-week Treatment With ALV003 In Patients With Well-Controlled Celiac Disease | |||||||||||||
Medical condition: Celiac Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002307-18 | Sponsor Protocol Number: 2020-002307-18 | Start Date*: 2021-02-10 | |||||||||||
Sponsor Name:Oslo University Hospital | |||||||||||||
Full Title: A phase IIa, double-blind, randomised, placebo-controlled study on the efficacy and tolerability of a 14-day treatment with teriflunomide 14 mg tablets vs. placebo in subjects with well-controlled ... | |||||||||||||
Medical condition: Coeliac disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002241-30 | Sponsor Protocol Number: CEC-3/CEL | Start Date*: 2018-01-30 | |||||||||||
Sponsor Name:Dr. Falk Pharma GmbH | |||||||||||||
Full Title: A phase IIa, double-blind, randomised, placebo-controlled, dose-finding study on the efficacy and tolerability of a 6-week treatment with ZED1227 capsules vs. placebo in subjects with well-controll... | |||||||||||||
Medical condition: Treatment of celiac disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Completed) FI (Completed) DE (Completed) AT (Completed) IE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003647-19 | Sponsor Protocol Number: CELIM-NRCD-001 | Start Date*: 2016-02-22 |
Sponsor Name:Celimmune LLC | ||
Full Title: A Phase 2a, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients with Celiac Disease. | ||
Medical condition: Celiac disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
